Neoadjuvant chemotherapy followed by chemoradiation and surgery with and without cetuximab in patients with resectable esophageal cancer: a randomized, open-label, phase III trial (SAKK 75/08)

Publication

Neoadjuvant chemotherapy followed by chemoradiation and surgery with and without cetuximab in patients with resectable esophageal cancer: a randomized, open-label, phase III trial (SAKK 75/08)

Journal Paper/Review - Jun 1, 2018

Ruhstaller Thomas, Mingrone W, Montemurro M, Girschikofsky M, Schmidt S C, Bitzer M, Bedenne L, Brauchli P, Stahl M, Hess V, Mariette C, Hawle H, Thuss-Patience P, Hayoz S, Schacher S, Knorrenschild J R, Schnider A, Plasswilm L, Budach W, Eisterer W, Swiss Group for Clinical Cancer Research (SAKK), the German Esophageal Cancer Study Group, the Austrian ‘Arbeitsgemeinschaft Medikamentöse Tumortherapie’ (AGMT), and the Fédération Francophone de Cancérologie Digestive (FFCD)/Fédération de Recherche en Ch

Ruhstaller, Thomas

Thuss-Patience, P

Hayoz, S

Schacher, S

Knorrenschild, J R

Schnider, A

Plasswilm, L

Budach, W

Eisterer, W

Hawle, H

Mariette, C

Hess, V

Mingrone, W

Montemurro, M

Girschikofsky, M

Schmidt, S C

Bitzer, M

Bedenne, L

Brauchli, P

Stahl, M